BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32901865)

  • 1. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide‑1.
    Granger CJ; Hoyt AK; Moran A; Becker B; Sedani A; Saigh S; Conway SA; Brown J; Galoian K
    Mol Med Rep; 2020 Nov; 22(5):3747-3758. PubMed ID: 32901865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
    Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
    Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRP‑1 significantly decreases the ALDHhigh cancer stem cell population and regulates the aberrant Wnt/β‑catenin pathway in human chondrosarcoma JJ012 cells.
    Hoyt AK; Moran A; Granger C; Sedani A; Saigh S; Brown J; Galoian KA
    Oncol Rep; 2019 Jul; 42(1):103-114. PubMed ID: 31180539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model.
    Palubeckaitė I; Venneker S; van den Akker BEWM; Briaire-de Bruijn IH; Boveé JVMG
    Clin Orthop Relat Res; 2023 Mar; 481(3):608-619. PubMed ID: 36729612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renieramycin M Attenuates Cancer Stem Cell-like Phenotypes in H460 Lung Cancer Cells.
    Sirimangkalakitti N; Chamni S; Suwanborirux K; Chanvorachote P
    Anticancer Res; 2017 Feb; 37(2):615-621. PubMed ID: 28179308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
    Alowaidi F; Hashimi SM; Alqurashi N; Alhulais R; Ivanovski S; Bellette B; Meedenyia A; Lam A; Wood S
    Oncol Rep; 2018 Jun; 39(6):2881-2891. PubMed ID: 29693155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of embryonic stem cell marker miR302C in human chondrosarcoma as determinant of antiproliferative activity of proline-rich polypeptide 1.
    Galoian K; Qureshi A; D'Ippolito G; Schiller PC; Molinari M; Johnstone AL; Brothers SP; Paz AC; Temple HT
    Int J Oncol; 2015 Aug; 47(2):465-72. PubMed ID: 26094604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of cancer stem cells by agarose multi-well dishes and 3D spheroid culture.
    Guo X; Chen Y; Ji W; Chen X; Li C; Ge R
    Cell Tissue Res; 2019 Feb; 375(2):397-408. PubMed ID: 30244317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morpho‑functional study of the hypothalamic proline‑rich polypeptide apoptotic activity against mouse Ehrlich ascites carcinoma.
    Abrahamyan S; Sahakyan I; Tumasyan N; Kocharyan N; Simonyan A; Aroutiounian R; Chailyan G; Chailyan S; Davtyan T; Galoian K
    Oncol Rep; 2020 Jul; 44(1):196-212. PubMed ID: 32377754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer.
    Shaheen S; Ahmed M; Lorenzi F; Nateri AS
    Stem Cell Rev Rep; 2016 Aug; 12(4):492-9. PubMed ID: 27207017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin targets gastric cancer stem cells.
    Courtois S; Durán RV; Giraud J; Sifré E; Izotte J; Mégraud F; Lehours P; Varon C; Bessède E
    Eur J Cancer; 2017 Oct; 84():193-201. PubMed ID: 28822889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening.
    Goričan L; Gole B; Potočnik U
    Cells; 2020 Jul; 9(7):. PubMed ID: 32708734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
    Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
    Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines.
    Shimamura M; Nagayama Y; Matsuse M; Yamashita S; Mitsutake N
    Endocr J; 2014; 61(5):481-90. PubMed ID: 24531915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Renewal and CSCs In Vitro Enrichment: Growth as Floating Spheres.
    Mehta P; Novak C; Raghavan S; Ward M; Mehta G
    Methods Mol Biol; 2018; 1692():61-75. PubMed ID: 28986887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
    Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
    Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.